EA200501221A1 - Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения - Google Patents

Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения

Info

Publication number
EA200501221A1
EA200501221A1 EA200501221A EA200501221A EA200501221A1 EA 200501221 A1 EA200501221 A1 EA 200501221A1 EA 200501221 A EA200501221 A EA 200501221A EA 200501221 A EA200501221 A EA 200501221A EA 200501221 A1 EA200501221 A1 EA 200501221A1
Authority
EA
Eurasian Patent Office
Prior art keywords
salts
preparation
pharmaceutical composition
airs
complex
Prior art date
Application number
EA200501221A
Other languages
English (en)
Other versions
EA009333B1 (ru
Inventor
Миха Яклиц
Власта Хумар
Хелена Сукье-Дебеляк
Юдита Сирца
Милойка Мохар
Original Assignee
Лек Фармасьютиклз Д. Д.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лек Фармасьютиклз Д. Д. filed Critical Лек Фармасьютиклз Д. Д.
Publication of EA200501221A1 publication Critical patent/EA200501221A1/ru
Publication of EA009333B1 publication Critical patent/EA009333B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В изобретении описаны пероральная фармацевтическая композиция с алендроновой кислотой, ее солями или сложными эфирами и способ ее получения.
EA200501221A 2003-02-27 2004-02-26 Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения EA009333B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200300052A SI21403A (sl) 2003-02-27 2003-02-27 Farmacevtska oblika z alendronsko kislino, njenimi solmi ali estri ter postopek za njeno pripravo
PCT/SI2004/000011 WO2004075828A2 (en) 2003-02-27 2004-02-26 Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation

Publications (2)

Publication Number Publication Date
EA200501221A1 true EA200501221A1 (ru) 2006-04-28
EA009333B1 EA009333B1 (ru) 2007-12-28

Family

ID=32906916

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501221A EA009333B1 (ru) 2003-02-27 2004-02-26 Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения

Country Status (8)

Country Link
EP (1) EP1599191B1 (ru)
AT (1) ATE464884T1 (ru)
CA (1) CA2517372C (ru)
DE (1) DE602004026689D1 (ru)
EA (1) EA009333B1 (ru)
PL (1) PL377706A1 (ru)
SI (1) SI21403A (ru)
WO (1) WO2004075828A2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781258A1 (en) * 2004-08-20 2007-05-09 Mepha AG Formulations of bisphosphonates
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
PE20070698A1 (es) * 2005-11-14 2007-08-17 Teijin Pharma Ltd Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
WO2009018834A1 (en) * 2007-08-06 2009-02-12 Pharmathen S.A. Pharmaceutical composition containing bisphosphonate and method for the preparation thereof
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
JP6521564B2 (ja) * 2010-12-22 2019-05-29 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 速崩性の固体被覆剤形
CN116211818B (zh) * 2023-03-10 2024-04-09 菲洋生物科技(吉林)有限公司 一种含有阿仑膦酸钠的片剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121623A (en) * 1997-08-26 2000-06-29 Unipharm Ltd Process for the preparation of solid oral dosage forms comprising alendronic acid
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AU1195001A (en) * 1999-10-11 2001-04-23 Monsanto Company Tablets coated with locust bean gum, guar gum or carrageenan gum
US6476006B2 (en) * 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates

Also Published As

Publication number Publication date
PL377706A1 (pl) 2006-02-06
EA009333B1 (ru) 2007-12-28
CA2517372C (en) 2012-07-17
CA2517372A1 (en) 2004-09-10
SI21403A (sl) 2004-08-31
EP1599191A2 (en) 2005-11-30
WO2004075828A3 (en) 2004-10-28
EP1599191B1 (en) 2010-04-21
ATE464884T1 (de) 2010-05-15
WO2004075828A2 (en) 2004-09-10
DE602004026689D1 (de) 2010-06-02

Similar Documents

Publication Publication Date Title
CY1110318T1 (el) Παραγωγα φαινοξυοξικου οξεος
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
ECSP024341A (es) Composiciones farmaceuticas
ATE457719T2 (de) Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel
WO2010078486A3 (en) Opioid-containing oral pharmaceutical compositions and methods
WO2008022932A3 (en) Controlled release system and method for manufacturing the same
DE602005000765D1 (de) Verfahren zur Herstellung von Ivabradine und deren pharmazeutisch verträgliche Säureadditionssalze
WO2007078874A3 (en) Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
CY1112115T1 (el) Παραγωγα φαινοξυοξικου οξεος χρησιμα για τη θεραπευτικη αντιμετωπιση ασθενειων του αναπνευστικου
EA200700387A1 (ru) Гидраты и полиморфы 4-[[(7r)-8-циклопентил-7-этил-5,6,7,8-тетрагидро-5-метил-6-оксо-2-птеридинил]амино]-3-метокси-n-(1-метил-4-пиперидинил)бензамида, способы их получения и их применение в качестве лекарственных средств
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
DE50201306D1 (de) Verfahren zur kontinuierlichen herstellung inhalierfähiger arzneistoffe
CY1124650T1 (el) Φαρμακευτικο παρασκευασμα που περιεχει ινσουλινη σε κρυσταλλικη μορφη καθως και σε διαλυτοποιημενη μορφη
ATE429903T1 (de) Pharmazeutische zubereitung mit verzögerter wirkstoff-freisetzung enthaltend milchsäure- glycolsäure copolymer, und verfahren zu deren herstellung
BRPI0817275A2 (pt) Combinação farmacêutica de alisquireno e valsartana
EA200501221A1 (ru) Фармацевтическая композиция алендроновой кислоты, ее солей или сложных эфиров и способ ее получения
DE60120109D1 (de) Verfahren zur herstellung von optisch-reinen (r)- und (s)- didesmethylsibutramin
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
WO2005046727A3 (en) Ibuprofen-containing soft gelatin capsules
DE602004014805D1 (de) Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
WO2005063219A3 (en) Ibuprofen-containing soft gelatin capsules
IL172663A0 (en) A process for the preparation of ??-(phenoxy)phenylacetic acid derivatives
WO2009100107A3 (en) Alendronate formulations, method of making and method of use thereof
HUP0401525A2 (en) Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): KZ RU